Clinical Trials Directory

Trials / Completed

CompletedNCT05924139

Omega-3 Fatty Acid Supplementation to Enhance Performance

Omega-3 Fatty Acid Supplementation to Enhance Performance in Collegiate Athletes

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Baylor University · Academic / Other
Sex
All
Age
18 Years – 25 Years
Healthy volunteers
Accepted

Summary

The goal of this intervention study is to determine if omega-3 fatty acid supplementation as compared to placebo improves performance in track and field athletes. The main questions it aims to answer are: 1. Can performance be improved 2. Can strength be enhanced 3. Will positive body composition changes occur (lean vs fat mass) 4. Will feelings of muscle soreness be diminished Participants will take either omega-3 fatty acid supplements or placebo and continue with their sport specific training regimen. Researchers will compare the supplement group to placebo group to determine if there are any significant differences.

Detailed description

This is a randomized, placebo-controlled trial to determine the efficacy of fish oil-derived omega-3 fatty acid supplementation. Up to sixty participants will be randomized to receive one of two conditions: 4.0 grams of FO n-3/day or placebo (coconut oil) for the 10-week protocol study period. Nordic Naturals (Ultimate Omega) will be used as the intervention at a dose of 6 capsules/day (3840 mg total FO/1950 mg EPA/1350 mg DHA). Although protocols have varied among studies with regards to dosage, the proposed regimen was selected based on studies on strength in older adults and college-aged athletes utilizing a range of 2-5g FO n-3 per day. Blinded randomization will be accomplished with a research associate providing every first (of two) participants the placebo, while the second will receive the supplemented condition until recruitment is complete. Participants will be provided their supplement in 2-week increments and instructed to consume with/near their evening meal. Used bottles will be returned after two weeks and participants will receive the next 2-week supply of supplement and the leftover pill count will determine compliance rate. The target population is apparently healthy college athletes (male and female of all ethnicities) between the ages of 18-25 years at Baylor University. Participants must be able to read and understand English and sign their own consent form. Up to 60 subjects will be recruited via direct contact or team briefings with permission of the coaches.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOmega-3 fatty acid6 capsules per day of 3840 mg that included 1950 mg EPA and 1350 mg DHA
DIETARY_SUPPLEMENTPlacebo4 capsules per day of coconut oil

Timeline

Start date
2023-03-06
Primary completion
2023-05-10
Completion
2023-06-02
First posted
2023-06-29
Last updated
2023-06-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05924139. Inclusion in this directory is not an endorsement.